Ibandronate Sodium Injection, Solution
Product Images NDC 55150-191

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Ibandronate Sodium (NDC 55150-191). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 Mean Percent Change (95% Confidence Interval) From Baseline In Lumbar Spine Bmd At One Year In Patients Treated With Ibandronate 2.5 mg Daily Oral Tablet Or Ibandronate Sodium Injection 3 mg Once Every 3 Months (Ibandronate Fig1)

This is a medical report on treatment options for lumbar spine bone mineral density (BMD) increase. It suggests two dosage options- 2.5 mg daily or 3mg every 3 months. The efficacy of the treatment options is compared, and the 3mg every 3 months dose appears to be more beneficial in increasing BMD. The comparison between the two doses is statistically significant with a p-value of less than 0.001.*

FDA Label Image

Package Label-principal Display Panel (3 mg per 3 mL (1 mg / mL))

FDA Label Image

Package Label-principal Display Panel (3 mg per 3 mL (1 mg / mL))

This is a description of a medication called Ibandronate Sodium, which is prescribed and distributed under FDA regulations. It is a sterile solution for injection, to be administered intravenously, and contains 3 milligrams per 3 milliliters, with a concentration of 1 milligram per milliliter. The drug is manufactured in India, and is distributed in the US by AuroMedics Pharma LLC.*

FDA Label Image

Package Label-principal Display Panel (3 mg per 3 mL (1 mg / mL))

This is a description of a medication called Ibandronate Sodium. It is a single-dose prefilled syringe containing 3 mg per 3 mL (1 mg / mL) intended for intravenous use only. The pharmacist is instructed to dispense the enclosed medication guide to each patient. The usual dosage is for intravenous administration over a period of 15 to 30 seconds. The medication is distributed by AuroMedics Pharma LLC and made in India. The storage temperature recommended is between 20°C and 25°C (68°F to 77°F). The NDC code for this medication is 55150-191-63.*

FDA Label Image

Ibandronate Fig5

This is a pharmaceutical product containing Ibandronate Sodium in the form of a single-dose prefilled syringe, injection and needle used for intravenous administration. Each carton contains one syringe of 3 mg Ibandronate Sodium (1 mg/mL) and sterile, to be administered using the provided needle. The product comes with a medication guide recommended to be given to each patient. It is for prescription use only. The manufacturer is NAL'ROMEDICS, and the product is coded TSDRUGS/132010, with an NDC of 55150-191-83.*

FDA Label Image

Ibandronate Sodium Chemical Structure (Ibandronate Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.